FDA Delays Final Rule on Intended Uses
By Michael Mezher -
Published 17 March 2017
The US Food and Drug Administration (FDA) on Friday announced it will delay implementation of its final rule clarifying when tobacco products are regulated as medical products until March 2018 in response to a petition from biopharmaceutical industry groups that raised questions about how the rule would alter the agency's definition of intended uses for drugs and medical devices.
Categories: News, US, FDA, Biologics and biotechnology, Communication, Drugs, Medical Devices
Tags: Intended Use, Final Rule, Totality of Evidence